CircuLex S100A7/Psoriasin ELISA Kit

CircuLex S100A7/Psoriasin ELISA Kit.



The CycLex Research Product CircuLex S100A7/Psoriasin ELISA Kit is used for the quantitative measurement of human S100A7/Psoriasin in washing fluid from skin, nipple fluid, tissue culture medium and other biological samples probably including serum, plasma. It can be used for 96 Assays.

Target: S100A7/Psoriasin         
Product Type: ELISA Kit
Size: 96 Assays
Application: ELISA
Research Area / Disease: Metabolism, Neuroscience
Sensitivity: better than 0.12 ng/ml of sample.
Measurement Range: Dilution factors need to be taken into consideration in calculating the human S100A7/Psoriasin concentration. Results exceeding human S100A7/Psoriasin level of 90 ng/ml should be repeated with diluted samples.
Regulatory Statement: For Research Use Only. Not for use in diagnostic procedures.


  • Microplate
  • 10X Wash Buffer
  • Dilution Buffer
  • Human S100A7/Psoriasin Standard
  • HRP conjugated Detection Antibody
  • Substrate Reagent
  • Stop Solution


  1. Cecchettini, Antonella, et al. “Phenotyping multiple subsets in Sjögren’s syndrome: a salivary proteomic SWATH-MS approach towards precision medicine.” Clinical proteomics 16.1 (2019): 1-11.
  2. Alvendal, Cathrin, et al. “Expression of Psoriasin in Human Papillomavirus–Induced Cervical High-Grade Squamous Intraepithelial Lesions.” Journal of Lower Genital Tract Disease 23.1 (2019): 33-38.
  3. Nienhouse V et al. Interplay between bladder microbiota and urinary antimicrobial peptides: mechanisms for human urinary tract infection risk and symptom severity. PLoS One. 9, e114185 (2014)
  4. Jansen S et al. Expression and function of psoriasin (S100A7) and koebnerisin (S100A15) in the brain. Infect Immun. 81, 1788-97 (2013),
  5. Salama RH et al. Psoriasin: a novel marker linked obesity with psoriasis. Dis Markers. 34, 33-9 (2013)


  1. Madsen P, Rasmussen HH & Leffers H et al. Molecular cloning, occurrence, and expression of a novel partially secreted protein “psoriasin” that is highly up-regulated in psoriatic skin. J Invest Dermatol (1991) 97: 701–712.
  2. Broome AM, Ryan D & Eckert RL. S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem (2003) 51: 675–685.
  3. Hitomi J, Yamaguchi K & Kikuchi Y et al. A novel calcium-binding protein in amniotic fluid, CAAF1: Its molecular cloning and tissue distribution. J Cell Sci (1996) 109: 805–815.
  4. Katz AB & Taichman LB. A partial catalog of proteins secreted by epidermal keratinocytes in culture. J Invest Dermatol (1999) 112: 818–821.
  5. Karimi-Busheri F, Marcoux Y & Tredget EE et al. Expression of a releasable form of annexin II by human keratinocytes. J Cell Biochem (2002) 86: 737–747.
  6. Hoffmann HJ, Olsen E & Etzerodt M et al. Psoriasin binds calcium and is upregulated by calcium to levels that resemble those observed in normal skin. J Invest Dermatol (1994) 103: 370–375.
  7. Jinquan T, Vorum H & Larsen CG et al. Psoriasin: A novel chemotactic protein. J Invest Dermatol (1996) 107: 5–10.
  8. Algermissen B, Sitzmann J, LeMotte P & Czarnetzki B. Differential expression of CRABP II, psoriasin and cytokeratin 1 mRNA in human skin diseases. Arch Dermatol Res (1996) 288: 426–430.
  9. Alowami S, Qing G & Emberley E et al. Psoriasin (S100A7) expression is altered during skin tumorigenesis. BMC Dermatol (2003) 3: 1.
  10. Glaser, R.; Harder, J.; Lange, H.; Bartels, J.; Christophers, E.; Schroder, J.-M. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nature Immun. (2005) 6: 57-64
Code CY-8073
Product Type ELISA Kit
Size 96 Assays
Application ELISA